3630 results for «2266»
3630 results
TAVI complications - Prediction, reduction, avoidance
21 May 2026 – From EuroPCR 2026
This session examines prediction, reduction, and avoidance of complications associated with TAVI procedures. It covers outcomes of second-valve implantation as a bail-out for valve migration, predictors of permanent pacemaker implantation post-TAVI from the LANDMARK trial, neurological event prognostics based on timing, and management of periprocedural cardiac...
CTO ADVANCED Level III: LIVE Educational Cases from Institut Cardiovasculaire Paris Sud, France & University Hospital Basel, Switzerland
21 May 2026 – From EuroPCR 2026
This advanced educational session features live complex chronic total occlusion (CTO) PCI cases from Institut Cardiovasculaire Paris Sud and University Hospital Basel. It emphasizes optimizing strategy selection, procedural efficiency across diverse CTO anatomies, and integrating advanced techniques into routine complex practice.
Bailout techniques for complications during primary PCI
21 May 2026 – From EuroPCR 2026
This session addresses bailout techniques during primary PCI complications. It covers a range of challenging scenarios such as coronary perforations and complex procedural issues, emphasizing rapid decision-making and effective treatment strategies to improve patient outcomes in high-stakes situations.
Left main complications - Part 1
21 May 2026 – From EuroPCR 2026
Focus on managing complications related to left main coronary interventions, with detailed case analyses addressing procedural pitfalls, iatrogenic dissections, and unexpected imaging challenges.
Innovative strategy in ACS
20 May 2026 – From EuroPCR 2026
Focusing on innovative strategies in acute coronary syndrome (ACS), this session reviews recent advances including drug-coated balloons in STEMI, early discharge safety guided by microcirculatory resistance indices, intravascular lithotripsy for coronary calcification in ACS, and novel stenting protocols demonstrated in randomized trials, providing a comprehensive update...
Outcomes in tricuspid valve intervention
19 May 2026 – From EuroPCR 2026
This session reviews contemporary clinical outcomes of tricuspid valve interventions. Topics include interim results from the Cardiovalve replacement system trial, the impact of atrial fibrillation on tricuspid TEER, residual regurgitation implications, afterload mismatch post-intervention, and long-term bioprosthetic valve durability.
New evidence for the use of DCB
20 May 2026 – From EuroPCR 2026
This session reviews emerging evidence supporting the use of drug-coated balloons (DCB) in complex PCI. It covers data from recent trials such as SELUTION De Novo, studies on vascular healing, restenosis patterns, long-term outcomes compared to DES, and optimal side branch treatment in bifurcation lesions.
New data in DCB outcomes
20 May 2026 – From EuroPCR 2026
Explore emerging evidence on drug-coated balloon (DCB) outcomes, featuring intravascular lithotripsy combined with DCB in calcified small vessels, OCT-guided PCI registries, predictors of angiographic success post-sirolimus-coated balloon angioplasty, and clinical impact in multivessel coronary artery disease management.
New evidence for coronary physiology in epicardial disease
20 May 2026 – From EuroPCR 2026
Explore new evidence in coronary physiology related to epicardial disease through analyses of landmark trials and registries. Topics include five-year follow-up data from DEFINE-FLAIR and iFR-SWEDEHEART, complete revascularization in elderly myocardial infarction patients, angiography-derived versus pressure wire assessments, prognostic implications of CT angiography-derived physiology, and the...
TAVI: head-to-head trials
20 May 2026 – From EuroPCR 2026
This session presents head-to-head comparisons of TAVI devices from recent randomized trials and registries. Highlights include three-year outcomes from the SMART trial, two-year data from the LANDMARK trial on contemporary valves, comparisons of intra- and supra-annular self-expanding valves, evaluations in large annuli, the ALLEGRA trial focusing...
New evidence for coronary revascularisation
21 May 2026 – From EuroPCR 2026
This session highlights new evidence in coronary revascularisation, including the role of CT-derived virtual stenting for procedural optimization, left ventricular unloading during complex PCI, long-term outcomes of FFR-guided PCI versus medical therapy, Impella CP support in high-risk PCI, and comparative results of PCI versus CABG in...
Major Late-Breaking Trials from EuroPCR 2026
20 May 2026 – From EuroPCR 2026
This session presents major late-breaking trials from EuroPCR 2026, reviewing contemporary evidence on coronary revascularization in TAVI patients, long-term outcomes of PCI versus CABG for left main disease, and comparative effectiveness of LAA closure versus NOAC in atrial fibrillation across age groups, with clinical practice implications.
Advancing TAVI practice
21 May 2026 – From EuroPCR 2026
Advancing TAVI practice is the focus of this session, addressing antiplatelet therapy choices, novel transcatheter treatments for pure aortic regurgitation, early hemodynamic valve deterioration as a prognostic marker, prosthesis-patient mismatch in redo-TAVI, pioneering valve-in-mechanical valve interventions, and comprehensive core-lab evaluation of implantation depth and clinical outcomes.
Complex bifurcation PCI: LIVE Educational Case from Leipzig Heart Centre - Leipzig, Germany
21 May 2026 – From EuroPCR 2026
Through a live educational case from Leipzig Heart Centre, this session addresses the complexities of bifurcation PCI. It discusses criteria defining complex bifurcation lesions, management strategies for challenging side branch access, and evaluates treatment options for true bifurcation lesions. The session includes patient presentation, detailed imaging...
Physiology-guided PCI: LIVE Educational Case from Sant'Andrea University Hospital - Rome, Italy
19 May 2026 – From EuroPCR 2026
This educational session presents a live, physiology-guided PCI case from Sant'Andrea University Hospital, Rome. It emphasizes the role of integrated functional imaging in procedural planning, discusses treatment strategies for multivessel disease and long lesions, and demonstrates a step-by-step fractional flow reserve (FFR)-guided PCI approach.
TAVI procedural complications - Part 5: vascular complications, coronary issues and more
20 May 2026 – From EuroPCR 2026
This session addresses procedural complications during TAVI, focusing on vascular complications, coronary issues, and rare device-related events. It includes case analyses of aortic dissection, valve infolding, stent dislodgement, and management strategies for complex anatomical challenges.
CTO PCI: how to prevent and manage complications effectively?
19 May 2026 – From EuroPCR 2026
Focused on chronic total occlusion (CTO) PCI, this session highlights the critical importance of procedural planning to minimize complications. Through detailed case analyses of coronary dissection and perforation, it outlines early identification strategies and equips clinicians with essential tools and techniques for effective complication management in...
Rescue techniques for coronary interventions
20 May 2026 – From EuroPCR 2026
This session presents an array of advanced rescue techniques employed in coronary interventions when unexpected complications arise. It features real-world cases including management of complex coronary artery aneurysms, malignant pericardial tamponade, challenging primary PCI scenarios, and innovative bailout strategies such as self-made covered stents and guidewire...
Advanced heart failure: left ventricular assist device as bridge to optimise guided-directed medical therapy
21 May 2026 – From EuroPCR 2026
This session explores advanced heart failure management with a focus on guided-directed medical therapy and the role of left ventricular assist devices (LVAD) as a bridge to therapy optimization. It discusses clinical, imaging, and biological parameters indicating LVAD use and highlights devices such as the Impella...
How to safely perform a retrograde CTO PCI: step-by-step guidance
20 May 2026 – From EuroPCR 2026
This session offers step-by-step guidance on safely performing retrograde chronic total occlusion (CTO) percutaneous coronary intervention (PCI). It covers the fundamentals of retrograde setup and collateral crossing, execution of a controlled reverse CART technique, and addresses common pitfalls with practical tips to improve procedural success and...